Sunday, July 6, 2025 7/6/2025

Optimizing COVID-19 Infection Prevention & Control in Clinical Practice

Award Number: NU50CK000574
ORGANIZATION: NATIONAL CENTER FOR ZOONOTIC, VECTOR-BORNE, AND ENTERIC DISEASES
OPDIV: CDC
AWARD CLASS: DISCRETIONARY
AWARD ACTIVITY TYPE: HEALTH SERVICES
PERIOD OF PERFORMANCE START DATE: 12/01/2020
PERIOD OF PERFORMANCE END DATE: 09/29/2025

Group Awards By:

View Award Description

Optimizing COVID-19 Infection Prevention & Control in Clinical Practice - Project Abstract Summary: The Infectious Diseases Society of America (IDSA), the nation’s leading infectious diseases medical society, proposes a multi-pronged strategy to support the maintenance of essential healthcare services to contain and prevent COVID-19 transmission, while keeping patients and healthcare workers safe and healthy. This proposal will focus on strategies that address Health Care Professionals (HCPs), with an emphasis on those serving individuals at increased risk for infectious diseases. IDSA will rapidly disseminate, and facilitate the adoption and implementation of, COVID-19 infection prevention and control (IPC) guidance among HCPs—including infectious disease (ID) physicians and other frontline workers who consistently engage in IPC of emerging and re-emerging infectious diseases. Our strategy will be realized by harnessing IDSA’s reach to the more than 12,000 IDSA members and ID physicians, scientists and other professionals committed to prevention, public health, education, research and patient care in health care settings severely affected by COVID-19. In doing so, IDSA will reach HCPs who care for underserved populations at increased risk of contracting COVID-19, including racial/ethnic minorities and individuals of low socio-economic status. IDSA will employ five strategies to achieve the short-, intermediate- and long-term outcomes of this project. Strategy 1: Disseminate & Adopt. COVID-19 Prevention and Control Guidance Dissemination. Activities to increase dissemination of guidance, clinical guidelines, and best practices to ID clinicians and other HCPs involved in COVID-19 IPC. Strategy 2: Inform & Adapt. CDC COVID-19 Guidance Feedback Program. Provide a pipeline of feedback to help CDC assess if front-line clinicians are comprehending and integrating guidance as part of their regular workday and finding it useful with patients. Strategy 3: Target & Train. COVID-19 Prevention & Control- Provider Engagement & Training. Engage and train frontline personnel in CDC guidance and best practices, leading to an extended workforce that is well-equipped to ensure adherence to COVID-19 IPC. Strategy 4: Integrate & Extend. Expansion of the CDC COVID-19 Real Time Learning Network (RTLN). Expand current RTLN to increase focus on COVID-19 IPC to assist CDC in developing cross-sub-specialty networks for information sharing & problem-solving. Strategy 5: Evaluate and Improve. COVID-19 IPC Performance & Quality Measurement. Develop a set of performance and quality measurement activities to assist CDC in evaluating the impact and effectiveness of CDC’s COVID-19 IPC guidance. Our senior leadership and nationwide member team have more than 40 years of technical experience designing, implementing and monitoring infection prevention and control programs, and are well versed in managing large, complex initiatives, including large-scale federal grants and awards. Over the 5 years of this program, IDSA will dedicate significant staff resources and numerous subject matter experts to support program design, delivery, measurement and evaluation, enabling us to successfully implement the above initiatives and meet desired outcomes.


Issue Date FY	Funding FY	Legal Entity Name	Legal Entity Address	Legal Entity City	Legal Entity State	Legal Entity Zip Code	Legal Entity COUNTY	Legal Entity COUNTRY	Assistance Listing	Award Code	Budget Year	Action Date	Action Type	Action Amount

Issue Date FY: 2025 ( Subtotal = $0 )
2025	2024	INFECTIOUS DISEASES SOCIETY OF AMERICA	4040 WILSON BLVD	ARLINGTON	VA	22203	ARLINGTON	USA	Protecting and Improving Health Globally: Building and Strengthening Public Health Impact, Systems, Capacity and Security	03	5	3/25/2025	ADMINISTRATIVE SUPPLEMENT ( + OR - ) (DISCRETIONARY OR BLOCK AWARDS)	$0
2025	2023	INFECTIOUS DISEASES SOCIETY OF AMERICA	4040 WILSON BLVD	ARLINGTON	VA	22203	ARLINGTON	USA	Protecting and Improving Health Globally: Building and Strengthening Public Health Impact, Systems, Capacity and Security	01	4	10/8/2024	ADMINISTRATIVE SUPPLEMENT ( + OR - ) (DISCRETIONARY OR BLOCK AWARDS)	$0
2025	2023	INFECTIOUS DISEASES SOCIETY OF AMERICA	4040 WILSON BLVD	ARLINGTON	VA	22203	ARLINGTON	USA	Protecting and Improving Health Globally: Building and Strengthening Public Health Impact, Systems, Capacity and Security	02	5	3/25/2025	ADMINISTRATIVE SUPPLEMENT ( + OR - ) (DISCRETIONARY OR BLOCK AWARDS)	$0
2025	2022	INFECTIOUS DISEASES SOCIETY OF AMERICA	4040 WILSON BLVD	ARLINGTON	VA	22203	ARLINGTON	USA	Protecting and Improving Health Globally: Building and Strengthening Public Health Impact, Systems, Capacity and Security	01	4	10/8/2024	ADMINISTRATIVE SUPPLEMENT ( + OR - ) (DISCRETIONARY OR BLOCK AWARDS)	$0
2025	2022	INFECTIOUS DISEASES SOCIETY OF AMERICA	4040 WILSON BLVD	ARLINGTON	VA	22203	ARLINGTON	USA	Protecting and Improving Health Globally: Building and Strengthening Public Health Impact, Systems, Capacity and Security	01	5	3/24/2025	ADMINISTRATIVE SUPPLEMENT ( + OR - ) (DISCRETIONARY OR BLOCK AWARDS)	$0
2025	2021	INFECTIOUS DISEASES SOCIETY OF AMERICA	4040 WILSON BLVD	ARLINGTON	VA	22203	ARLINGTON	USA	Protecting and Improving Health Globally: Building and Strengthening Public Health Impact, Systems, Capacity and Security	01	4	10/8/2024	ADMINISTRATIVE SUPPLEMENT ( + OR - ) (DISCRETIONARY OR BLOCK AWARDS)	$0
														Subtotal = $0

Issue Date FY: 2024 ( Subtotal = $400,000 )
2024	2024	INFECTIOUS DISEASES SOCIETY OF AMERICA	4040 WILSON BLVD	ARLINGTON	VA	22203	ARLINGTON	USA	Protecting and Improving Health Globally: Building and Strengthening Public Health Impact, Systems, Capacity and Security	00	5	7/31/2024	NON-COMPETING CONTINUATION	$400,000
2024	2023	INFECTIOUS DISEASES SOCIETY OF AMERICA	4040 WILSON BLVD	ARLINGTON	VA	22203	ARLINGTON	USA	Protecting and Improving Health Globally: Building and Strengthening Public Health Impact, Systems, Capacity and Security	00	5	7/31/2024	NON-COMPETING CONTINUATION	$0
2024	2022	INFECTIOUS DISEASES SOCIETY OF AMERICA	4040 WILSON BLVD	ARLINGTON	VA	22203	ARLINGTON	USA	Protecting and Improving Health Globally: Building and Strengthening Public Health Impact, Systems, Capacity and Security	00	5	7/31/2024	NON-COMPETING CONTINUATION	$0
2024	2021	INFECTIOUS DISEASES SOCIETY OF AMERICA	4040 WILSON BLVD	ARLINGTON	VA	22203	ARLINGTON	USA	Protecting and Improving Health Globally: Building and Strengthening Public Health Impact, Systems, Capacity and Security	00	5	7/31/2024	NON-COMPETING CONTINUATION	$0
														Subtotal = $400,000

Issue Date FY: 2023 ( Subtotal = $1,100,000 )
2023	2023	INFECTIOUS DISEASES SOCIETY OF AMERICA	4040 WILSON BLVD	ARLINGTON	VA	22203	ARLINGTON	USA	Protecting and Improving Health Globally: Building and Strengthening Public Health Impact, Systems, Capacity and Security	00	4	8/31/2023	NON-COMPETING CONTINUATION	$1,100,000
2023	2022	INFECTIOUS DISEASES SOCIETY OF AMERICA	4040 WILSON BLVD	ARLINGTON	VA	22203	ARLINGTON	USA	Protecting and Improving Health Globally: Building and Strengthening Public Health Impact, Systems, Capacity and Security	01	3	11/29/2022	ADMINISTRATIVE SUPPLEMENT ( + OR - ) (DISCRETIONARY OR BLOCK AWARDS)	$0
2023	2022	INFECTIOUS DISEASES SOCIETY OF AMERICA	4040 WILSON BLVD	ARLINGTON	VA	22203	ARLINGTON	USA	Protecting and Improving Health Globally: Building and Strengthening Public Health Impact, Systems, Capacity and Security	00	4	8/31/2023	NON-COMPETING CONTINUATION	$0
2023	2021	INFECTIOUS DISEASES SOCIETY OF AMERICA	4040 WILSON BLVD	ARLINGTON	VA	22203	ARLINGTON	USA	Protecting and Improving Health Globally: Building and Strengthening Public Health Impact, Systems, Capacity and Security	00	4	8/31/2023	NON-COMPETING CONTINUATION	$0
2023	2021	INFECTIOUS DISEASES SOCIETY OF AMERICA	4040 WILSON BLVD	ARLINGTON	VA	22203	ARLINGTON	USA	Protecting and Improving Health Globally: Building and Strengthening Public Health Impact, Systems, Capacity and Security	01	3	11/29/2022	ADMINISTRATIVE SUPPLEMENT ( + OR - ) (DISCRETIONARY OR BLOCK AWARDS)	$0
														Subtotal = $1,100,000

Issue Date FY: 2022 ( Subtotal = $3,769,548 )
2022	2022	INFECTIOUS DISEASES SOCIETY OF AMERICA	4040 WILSON BLVD	ARLINGTON	VA	22203	ARLINGTON	USA	Protecting and Improving Health Globally: Building and Strengthening Public Health Impact, Systems, Capacity and Security	00	3	8/19/2022	NON-COMPETING CONTINUATION	$3,769,548
2022	2021	Infectious Diseases Society Of America	4040 Wilson Blvd # 300	Arlington	VA	22203	ARLINGTON	USA	Protecting and Improving Health Globally: Building and Strengthening Public Health Impact, Systems, Capacity and Security	03	2	11/5/2021	ADMINISTRATIVE SUPPLEMENT ( + OR - ) (DISCRETIONARY OR BLOCK AWARDS)	$0
2022	2021	INFECTIOUS DISEASES SOCIETY OF AMERICA	4040 WILSON BLVD	ARLINGTON	VA	22203	ARLINGTON	USA	Protecting and Improving Health Globally: Building and Strengthening Public Health Impact, Systems, Capacity and Security	00	3	8/19/2022	NON-COMPETING CONTINUATION	$0
2022	2021	INFECTIOUS DISEASES SOCIETY OF AMERICA	4040 WILSON BLVD	ARLINGTON	VA	22203	ARLINGTON	USA	Protecting and Improving Health Globally: Building and Strengthening Public Health Impact, Systems, Capacity and Security	05	2	9/6/2022	ADMINISTRATIVE SUPPLEMENT ( + OR - ) (DISCRETIONARY OR BLOCK AWARDS)	$0
2022	2021	INFECTIOUS DISEASES SOCIETY OF AMERICA	4040 WILSON BLVD	ARLINGTON	VA	22203	ARLINGTON	USA	Protecting and Improving Health Globally: Building and Strengthening Public Health Impact, Systems, Capacity and Security	04	2	6/7/2022	ADMINISTRATIVE SUPPLEMENT ( + OR - ) (DISCRETIONARY OR BLOCK AWARDS)	$0
														Subtotal = $3,769,548

Issue Date FY: 2021 ( Subtotal = $6,860,000 )
2021	2021	Infectious Diseases Society Of America	4040 Wilson Blvd # 300	Arlington	VA	22203	ARLINGTON	USA	Protecting and Improving Health Globally: Building and Strengthening Public Health Impact, Systems, Capacity and Security	00	1	12/2/2020	NEW	$3,200,000
2021	2021	Infectious Diseases Society Of America	4040 Wilson Blvd # 300	Arlington	VA	22203	ARLINGTON	USA	Protecting and Improving Health Globally: Building and Strengthening Public Health Impact, Systems, Capacity and Security	01	1	12/17/2020	ADMINISTRATIVE SUPPLEMENT ( + OR - ) (DISCRETIONARY OR BLOCK AWARDS)	$0
2021	2021	Infectious Diseases Society Of America	4040 Wilson Blvd # 300	Arlington	VA	22203	ARLINGTON	USA	Protecting and Improving Health Globally: Building and Strengthening Public Health Impact, Systems, Capacity and Security	01	2	8/10/2021	ADMINISTRATIVE SUPPLEMENT ( + OR - ) (DISCRETIONARY OR BLOCK AWARDS)	$1,560,000
2021	2021	Infectious Diseases Society Of America	4040 Wilson Blvd # 300	Arlington	VA	22203	ARLINGTON	USA	Protecting and Improving Health Globally: Building and Strengthening Public Health Impact, Systems, Capacity and Security	03	1	4/9/2021	ADMINISTRATIVE SUPPLEMENT ( + OR - ) (DISCRETIONARY OR BLOCK AWARDS)	$0
2021	2021	Infectious Diseases Society Of America	4040 Wilson Blvd # 300	Arlington	VA	22203	ARLINGTON	USA	Protecting and Improving Health Globally: Building and Strengthening Public Health Impact, Systems, Capacity and Security	02	2	8/31/2021	ADMINISTRATIVE SUPPLEMENT ( + OR - ) (DISCRETIONARY OR BLOCK AWARDS)	$0
2021	2021	Infectious Diseases Society Of America	4040 Wilson Blvd # 300	Arlington	VA	22203	ARLINGTON	USA	Protecting and Improving Health Globally: Building and Strengthening Public Health Impact, Systems, Capacity and Security	00	2	7/7/2021	NON-COMPETING CONTINUATION	$2,100,000
2021	2021	Infectious Diseases Society Of America	4040 Wilson Blvd # 300	Arlington	VA	22203	ARLINGTON	USA	Protecting and Improving Health Globally: Building and Strengthening Public Health Impact, Systems, Capacity and Security	02	1	3/11/2021	ADMINISTRATIVE SUPPLEMENT ( + OR - ) (DISCRETIONARY OR BLOCK AWARDS)	$0
														Subtotal = $6,860,000

Grand Total All Awards = $12,129,548

Top

All Categories

About

Search

Reports

Data Submission

Award Information

Optimizing COVID-19 Infection Prevention & Control in Clinical Practice

Award Number: NU50CK000574

ORGANIZATION: NATIONAL CENTER FOR ZOONOTIC, VECTOR-BORNE, AND ENTERIC DISEASES

OPDIV: CDC

AWARD CLASS: DISCRETIONARY

AWARD ACTIVITY TYPE: HEALTH SERVICES

PERIOD OF PERFORMANCE START DATE: 12/01/2020

PERIOD OF PERFORMANCE END DATE: 09/29/2025

Federal Websites

Department of Health & Human Services

HHS Operating Divisions

HHS Staff Divisions

Download A Document Viewer